55 related articles for article (PubMed ID: 2946094)
1. [Marvelon--when adverse effects became marketing arguments].
Fjoerestad I
Tidsskr Nor Laegeforen; 1986 Aug; 106(22):1735-8. PubMed ID: 2946094
[No Abstract] [Full Text] [Related]
2. [Marvelon--when adverse effects become marketing arguments].
Fjaerestad I
Tidsskr Nor Laegeforen; 1986 Aug; 106(23):1865-6. PubMed ID: 2945284
[No Abstract] [Full Text] [Related]
3. [Marvelon--when the adverse effects become a marketing argument].
Hansson V
Tidsskr Nor Laegeforen; 1986 Apr; 106(11):966-8. PubMed ID: 2941893
[No Abstract] [Full Text] [Related]
4. Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance.
Rákóczi I; Gerö G; Demeter J; Gáti I
Arzneimittelforschung; 1985; 35(3):630-3. PubMed ID: 3158320
[TBL] [Abstract][Full Text] [Related]
5. [Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism].
Surico N; Porcelli A; Petrelli P; Amedeo M; Crivello T; Ferraris G
Minerva Ginecol; 1988 Sep; 40(9):559-62. PubMed ID: 2975773
[No Abstract] [Full Text] [Related]
6. Desogestrel-containing oral contraceptives and blood pressure.
Dieben TO; van Beek A
Arzneimittelforschung; 1986 Nov; 36(11):1678-80. PubMed ID: 2949757
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial of an oral contraceptive containing desogestrel and ethinyl estradiol.
Weijers MJ
Clin Ther; 1982; 4(5):359-66. PubMed ID: 6461412
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of a monophasic ethinylestradiol/desogestrel-containing oral contraceptive.
Bilotta P; Favilli S
Arzneimittelforschung; 1988 Jul; 38(7):932-4. PubMed ID: 2974702
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of desogestrel, the first new-generation progestagen, practil 21, on 13,290 women and 74,967 cycles].
Bilotta P; Favilli S
Minerva Ginecol; 1987 Dec; 39(12):855-69. PubMed ID: 3329705
[No Abstract] [Full Text] [Related]
10. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
Meurer LN; Slawson JG
J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
[No Abstract] [Full Text] [Related]
11. [Marvelon. A contraceptive pill with desogestrel, a new gestagenic substance].
Felding IC; Mikkelsen AL
Ugeskr Laeger; 1985 Oct; 147(42):3330-2. PubMed ID: 2934882
[No Abstract] [Full Text] [Related]
12. [Hormonal contraception with marvelon. Experiences with marvelon in gynecologic practice--a multicenter study by 265 gynecologists on over 26,000 women].
Geissler KH
Fortschr Med; 1983 Jun; 101(22):1060-4. PubMed ID: 6223870
[No Abstract] [Full Text] [Related]
13. Third generation oral contraceptives containing desogestrel and gestodene and the risk of thrombosis.
Griffin JP
Adverse Drug React Toxicol Rev; 1996 Mar; 15(1):5-7. PubMed ID: 8920631
[No Abstract] [Full Text] [Related]
14. Oral contraceptives and venous thromboembolism.
Graham A; Grieve F; Davie J; Glasier A
Lancet; 1995 Nov; 346(8987):1430. PubMed ID: 7475846
[No Abstract] [Full Text] [Related]
15. Guidelines for prescribing combined oral contraceptives.
Mills AM; Wilkinson CL; Bromham DR; Elias J; Fotherby K; Guillebaud J; Kubba A; Wade A
BMJ; 1996 Jan; 312(7023):121-2. PubMed ID: 8555906
[No Abstract] [Full Text] [Related]
16. Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
Coenen CM; Thomas CM; Borm GF; Rolland R
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():92-7. PubMed ID: 8574256
[TBL] [Abstract][Full Text] [Related]
17. Third generation oral contraceptive pills.
MacRae K; Kay C
BMJ; 1995 Oct; 311(7013):1112. PubMed ID: 7580698
[No Abstract] [Full Text] [Related]
18. Safety of combined oral contraceptive pills.
Cramer DW
Lancet; 1996 Feb; 347(9000):546-8. PubMed ID: 8596297
[No Abstract] [Full Text] [Related]
19. Influence of the third generation pill controversy on prescriptions for oral contraceptives among first time users: population based study.
de Jong-van den Berg L; Tobi H; Bijker B; van den Berg P
BMJ; 2003 Feb; 326(7383):254. PubMed ID: 12560275
[No Abstract] [Full Text] [Related]
20. The effects of desogestrel and ethinylestradiol combination in normal and hyperandrogenic young girls: speculations on contraception in adolescence.
Venturoli S; Porcu E; Gammi L; Fabbri R; Paradisi R; Flamigni C; Patrono D; Capelli M; Paoletti C
Acta Eur Fertil; 1988; 19(3):129-34. PubMed ID: 2976224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
